Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-192"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-192"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"The information supplied to patients should fulfil the following main characteristics:
Reliability: information to patients should be based on the latest scientific knowledge with clear references made to the sources this knowledge comes from;
Independence: it has to be clear who provides and who finances the information so that consumers can identify potential conflicts of interest;
Information should be easily accessible to consumers and patient-oriented: it should be comprehensible and easily available, taking into account the particular needs of consumers such as age, cultural differences and availability in all European languages. Information supplied to patients about prescription-only medicines should be part of a wider ‘information to patients’ strategy and a broader health education strategy.
Patients and anyone interested should be able to find accurate, unbiased information about having a healthy lifestyle, the prevention of illness and specific diseases and on the various treatment options. This is why I think that this proposal must be supplemented with a code of conduct concerning the information supplied to patients and drafted in cooperation with patients’ organisations. This will allow the ‘patients’ voice’ to be heard."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples